KT&G Q2 earnings: net profit falls 54% to $103 million, NGP revenue down 0.8% to $141 million

Aug.08.2025
 KT&G Q2 earnings: net profit falls 54% to $103 million, NGP revenue down 0.8% to $141 million
KT&G has released its financial report for the second quarter and first half of 2025. The company's first-half revenue surpassed 3 trillion won (approximately US$2.16 billion) for the first time, with second-quarter revenue increasing by 8.7% year-over-year to US$1.114 billion. Net profit decreased by 54.1% year-over-year to US$103 million.

Key points:

 

Core business data:

 • In the first half of 2025, sales exceeded ₩3 trillion KRW (approx. USD 2.16 billion) for the first time.
• Q2 revenue reached ₩1.5479 trillion KRW (approx. USD 1.114 billion), up 8.7% year-on-year.
• Q2 operating profit was ₩349.8 billion KRW (approx. USD 252 million), up 8.6% year-on-year.
• Q2 net profit stood at ₩143.5 billion KRW (approx. USD 103 million), down 54.1% year-on-year.
 

Traditional tobacco business: 

 • Domestic cigarette business revenue: ₩408.3 billion KRW (approx. USD 294 million), down 0.6% year-on-year.
• Overseas cigarette business revenue: ₩469.0 billion KRW (approx. USD 338 million), up 30.6% year-on-year.

 

Performance of new tobacco products: 

 • Revenue: ₩196.1 billion KRW (approx. USD 141 million), a slight 0.8% decline year-on-year.


 

According to KT&G’s official announcement on August 7, 2025, the Korea Tobacco & Ginseng Corporation (KT&G) released its financial results for Q2 and the first half of 2025.


Driven by strong growth in overseas cigarette business and real estate, the company’s first-half sales surpassed ₩3 trillion KRW (approx. USD 2.16 billion) for the first time in history. KT&G also announced an increase in its interim dividend and the launch of a large-scale share repurchase program to enhance shareholder returns.
 

 

Core financial performance (second quarter of 2025)

 

• Revenue: ₩1.5479 trillion KRW (approx. USD 1.114 billion), +8.7% YoY
• Operating Profit: ₩349.8 billion KRW (approx. USD 252 million), +8.6% YoY
• Net Income: ₩143.5 billion KRW (approx. USD 103 million), -54.1% YoY
• EPS: ₩1,328 KRW (approx. USD 0.96), -51.1% YoY
 

 KT&G Q2 earnings: net profit falls 54% to $103 million, NGP revenue down 0.8% to $141 million
Performance report data | Image source: KT&G

 

1.Business Segment Analysis (Second Quarter of 2025)

 

Tobacco business

 

Overseas Cigarettes
• Revenue: ₩469.0 billion KRW (approx. USD 338 million), +30.6% YoY
• Sales volume: 16.7 billion sticks, +9.1% YoY
• Adjusted operating profit: +51.1% YoY
• Regional sales distribution:
Asia-Pacific (APAC): 42.8%
Middle East & Africa (MEA): 31.3%
Americas, Europe & CIS (AME & CIS): 25.9%

 

Domestic Cigarettes
• Revenue: ₩408.3 billion KRW (approx. USD 294 million), -0.6% YoY
• Sales volume: 9.8 billion sticks, -5.14% YoY
• Market share continued to rise, reaching 0.6% in H1 2025.

 

New Tobacco (NGP – lil heated tobacco brand)
• Revenue: ₩196.1 billion KRW (approx. USD 141 million), -0.8% YoY
• Market penetration (NGP Penetration): 22.8% in H1 2025, up from 21.1% a year earlier.
• Market share leadership: heated tobacco stick share of market (Stick SoM) steady at 45.8% in H1 2025.
• Quarterly sales rebound: overseas heated tobacco stick sales reached 2.24 billion units in Q2 2025, +4.2% YoY, driven by expanded sales in markets such as Russia.

 

2. Health Functional Foods (KGC Ginseng Corporation)


• Revenue: ₩220.6 billion KRW (approx. USD 159 million).
• Operating profit: turned from a loss of ₩1.0 billion KRW (approx. USD 7.2 million) to a profit of ₩62 billion KRW (approx. USD 44.64 million).

 

3. Real Estate Business


• Revenue: up by ₩143.7 billion KRW (approx. USD 103 million) YoY.
• Operating profit: rose from ₩29 billion KRW (approx. USD 20.88 million) to ₩177 billion KRW (approx. USD 127 million).

 

Outlook & Shareholder Returns


• Annual targets: maintain rapid growth in overseas cigarette business, enhance global cost competitiveness, and achieve double-digit growth in full-year operating profit.
• Shareholder returns:
• Interim dividend per share: ₩1,400 KRW (approx. USD 1.01), up ₩200 YoY.
• Launch of ₩300 billion KRW (approx. USD 216 million) share buyback, with cancellation of shares upon completion.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
InterTabac 2026 opened in Dortmund, Germany, on September 15 alongside NUBIZ and InterSupply. According to the latest figures released by the organizer, the three trade shows bring together around 750 exhibitors from 64 countries. On site, 2Firsts observed vaping and related brands including VAPORESSO, DOJO, SKE, GREENTANK, GEEK BAR, HQD and ELUX.
Special Report
Sep.15
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden is expected to oppose a European Union proposal to raise minimum tobacco excise duties, Law360 reported on October 26, 2026, citing an EU official. A provisional Council agenda dated October 23 confirms that the tobacco taxation package is scheduled for discussion at the November 9 finance ministers' meeting, where member states will seek a general approach. The proposed reforms would raise minimum taxes on conventional tobacco products and establish EU-wide excise rules for vaping liquids, heated tobacco and nicotine pouches. Sweden supports harmonising tobacco taxation rules but objects to requiring nicotine pouches to bear the same minimum tax burden as certain smoking tobacco products. As EU indirect tax legislation requires unanimous Council approval, Swedish opposition could block the proposal in its current form.
Regulations
Oct.29